Encompass Health Corp (EHC) Stock Forecast & Price Target
Encompass Health Corp · NYSE
$115.93+2.05 (+1.80%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 6 firms covering Encompass Health Corp, 6 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $125.00 to $160.00, so the covering firms are broadly aligned. The average target of $142.50 sits 23% above the current $115.93. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.36 next quarter toward $6.54 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 ratings
Strong Buy
Strong Buy00%
Buy6100%
Hold00%
Sell00%
Strong Sell00%
Based on 6 analysts giving stock ratings to Encompass Health Corp.
As of Jul, 6 of 6 firms rate EHC a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
EHC EPS & revenue forecast
EPS · NEXT QUARTER
$1.36
Range $1.28 – $1.45 · 12 analysts · +10% YoY
Next period, 12 analysts expect Encompass Health Corp to earn $1.36 a share (range $1.28 – $1.45), versus $1.23 a year earlier. Full-year consensus is $6.00, growing to $6.54 the year after.
REVENUE · NEXT QUARTER
$1.6B
Range $1.6B – $1.6B · 12 analysts · +8% YoY
Revenue is expected to reach $1.6B (range $1.6B – $1.6B), +8.0% year-over-year. Full-year consensus is $6.4B, rising to $6.9B next year.
Top analysts covering Encompass Health Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EHC.
#1
DM
David Macdonald
Truist Securities · Rank #67
Buy
$140.00+20.8% to target
Overall win rate
51%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #117
Buy
$125.00+7.8% to target
Overall win rate
44%
+ Follow
#3
Paul Knight
Keybanc · Rank #296
Buy
$135.00+16.4% to target
Overall win rate
32%
+ Follow
#4
Andrew Mok
Barclays
Buy
$140.00+20.8% to target
Coverage
—
+ Follow
#5
MG
Matthew Gillmor
Keybanc
Buy
$140.00+20.8% to target
Coverage
—
+ Follow
EHC stock forecast FAQ
What is EHC's average 12-month price target?+
The 6 analysts with a live target average $142.50 for Encompass Health Corp over the next 12 months, ranging from a $160.00 high to a $125.00 low.
Is EHC stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 6 analyst ratings, 6 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for EHC?+
The Street-high target is $160.00 (B of A Securities), and the Street-low is $125.00 (TD Cowen). The average of all 6 active targets is $142.50.
How many Wall Street analysts cover EHC?+
6 analysts have an active rating on Encompass Health Corp, and 6 firms carry a live 12-month price target.
Who is the most accurate analyst covering EHC?+
Among analysts who currently cover EHC, David Macdonald of Truist Securities has the strongest overall Quantellect track record (Rank #67). Their current call is Buy with a $140.00 target.
What is Encompass Health Corp's projected EPS for next quarter?+
The consensus estimate is $1.36 per share (range $1.28 – $1.45) across 12 analysts. Full-year EPS is projected at $6.00, rising to $6.54 the following year.
How much revenue is Encompass Health Corp expected to report next quarter?+
Consensus revenue is $1.6B (range $1.6B – $1.6B). Full-year revenue is projected at $6.4B, growing to $6.9B next year.
Have analysts been upgrading or downgrading EHC lately?+
As of Jul, 6 of 6 firms rate EHC a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EHC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
